Immucell (ICCC) Capital Expenditures Growth (3y) (2013 - 2025)
Powered by 
Analysis
Immucell (ICCC) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | -3.55% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -11.01% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -7.72% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 20.10% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -51.28% |
| Sep 30, 2025 | -6.83% |
| Jun 30, 2025 | -45.21% |
| Mar 31, 2025 | -25.86% |
| Dec 31, 2024 | -34.70% |
| Sep 30, 2024 | -49.22% |
| Jun 30, 2024 | -49.88% |
| Mar 31, 2024 | -41.38% |
| Dec 31, 2023 | -34.13% |
| Sep 30, 2023 | -34.16% |
| Jun 30, 2023 | -12.64% |
| Mar 31, 2023 | -18.33% |
| Dec 31, 2022 | 29.17% |
| Sep 30, 2022 | 22.46% |
| Jun 30, 2022 | 107.40% |
| Mar 31, 2022 | 60.75% |
| Dec 31, 2021 | 92.52% |
| Sep 30, 2021 | 46.24% |
| Jun 30, 2021 | -65.17% |
| Mar 31, 2021 | -33.97% |